Member Companies

Membership in IQ is open to any corporation and/or any subsidiary thereof which is significantly engaged in the development of new chemical entities or new molecular entities for the prevention, diagnosis or treatment of disease. For information about joining the Consortium, please see Join IQ.

Current IQ Consortium members include:

AbbVie

Agios

Alnylam

Amgen, Inc.

Astellas Pharma US LLC

AstraZeneca Pharmaceuticals

Bayer HealthCare

BeiGene

Biogen

Blueprint Medicines

Boehringer Ingelheim

Bristol-Myers Squibb Company

Daiichi Sankyo

Eisai, Inc.

Eli Lilly and Company

EMD Serono

Genentech

Gilead Sciences

GlaxoSmithKline

Incyte Corporation

Johnson & Johnson

Merck & Co.

Mitsubishi Tanabe          

Novartis

Otsuka Pharmaceutical Co.

Pfizer

Roche

Sanofi

Sarepta

Seagen

Servier

Sunovion

Takeda

Teva Pharmaceutical

Theravance Biopharma

UCB Pharma

Vertex, Inc.